Replies to post #78119 on Biotech Values

[DewDiligence]

Bridgeofsighs et al: Comments on this product?

http://finance.yahoo.com/news/Stentys-Establishes-US-bw-15277018.html

“Stentys’ platform solves malapposition thanks to its self-expanding feature that ensures optimal apposition in the critical hours and days after the procedure. The stent is constantly applied to the vessel surface during thrombus and vessel spasm relief, as demonstrated in the successful initial clinical experience…”

T.i.a.

[microcapfun]

>>Why dedicate a surgical suite to a Davinci if you are doing three procedures a week?<<

You don't have to dedicate a surgical suite to a da Vinci because the damn thing is portable!! You can just roll it out of the way and carry on with open or lap procedures.

Plus the hospital takes in ~$100,000 for 3 procedures!


>>OK, I am done until the next quarterly report.<<

Which is precisely your problem ...

micro